KnoWhere Bio
Gyeongju
About KnoWhere Bio
KnoWhere Bio develops new anticancer drugs in the preclinical stage and produces new drugs such as diabetic retinopathy and type 2 diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2019)
- Website: knowherebio.com
Industries & Categories
Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/knowhere-bio-3742851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.